Antisense Approach for Clotting Disorders Whippany, NJ – WEBWIRE – Monday, May 04, 2015 Bayer HealthCare (Bayer) has entered into an exclusive license agreement with Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) […]
DUARTE, Calif.–(BUSINESS WIRE)–City of Hope and Fortress Biotech have reached an agreement to form a new subsidiary company, DiaVax Biosciences, that will develop two novel vaccines against cytomegalovirus infection, a […]
ST. PAUL, Minn.–(BUSINESS WIRE)–St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced it has completed the acquisition of Spinal Modulation, Inc., developer of the Axium™ Neurostimulator System. […]
At the recent American Association of Cancer Research (AACR) meeting, one of the most encouraging sets of presentations pertained to PARP inhibitors. What’s emerging is that this new class of […]
DUBLIN, IRELAND–(Marketwired – May 1, 2015) – Horizon Pharma plc (NASDAQ: HZNP), a specialty biopharmaceutical company focused on improving patients’ lives by identifying, developing, acquiring and commercializing differentiated products that […]
TORONTO, ON–(Marketwired – May 01, 2015) – This month’s free, educational webinars from Xtalks Life Sciences will feature global clinical trials, biomarkers, electronic data capture, eSourcing, clinical data, epigenetics, toxicology, […]